The features of the prevention of preeclampsia in pregnant women with gestational endotheliopathy in the first trimester

dc.contributor.author	Konkov, D.	en
dc.contributor.author	Taran, O.	en
dc.contributor.author	Klivak, V.	en
dc.contributor.author	Muntian, O.	en
dc.date.accessioned	2024-08-12T06:48:55Z	en
dc.date.available	2024-08-12T06:48:55Z	en
dc.date.issued	2024
dc.identifier.citation	The features of the prevention of preeclampsia in pregnant women with gestational endotheliopathy in the first trimester / D. Konkov, O. Taran, V. Klivak, O. Muntian // Italian Journal of Gynaecology and Obstetrics. – 2024. – № 36 (2). – P. 10. – DOI: 10.36129/jog.2024.S48.	en
dc.identifier.other	DOI: 10.36129/jog.2024.S48	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/6595	en
dc.description.abstract	The purpose of our clinical study is to evaluate the clinical effectiveness of L-arginine in the prevention of preeclampsia and reduction of other perinatal risks in patients with preclinical gestational endotheliopathy.	en
dc.language.iso	en	en
dc.publisher	Italian Journal of Gynaecology and Obstetrics	en
dc.subject	preeclampsia	en
dc.subject	maternal haemodynamic	en
dc.subject	acetylsalicylic acid	en
dc.subject	prevention	en
dc.subject	L-arginine	en
dc.title	The features of the prevention of preeclampsia in pregnant women with gestational endotheliopathy in the first trimester	en
dc.type	Thesis	en